Seizert Capital Partners’s Johnson & Johnson JNJ Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$41.9M Sell
171,341
-58,131
-25% -$13.5M 1.93% 23
2025
Q4
$47.5M Sell
229,472
-10,698
-4% -$2.12M 2.01% 21
2025
Q3
$44.5M Sell
240,170
-3,544
-1% -$607K 1.93% 24
2025
Q2
$37.2M Sell
243,714
-1,441
-0.6% -$221K 1.64% 31
2025
Q1
$40.7M Buy
245,155
+3,385
+1% +$530K 1.86% 24
2024
Q4
$35M Sell
241,770
-2,287
-0.9% -$354K 1.58% 31
2024
Q3
$39.6M Buy
244,057
+2,441
+1% +$389K 1.79% 23
2024
Q2
$35.3M Sell
241,616
-11,839
-5% -$1.76M 1.75% 22
2024
Q1
$40.1M Buy
253,455
+3,125
+1% +$497K 1.85% 20
2023
Q4
$39.2M Sell
250,330
-11,632
-4% -$1.78M 1.99% 18
2023
Q3
$40.8M Buy
261,962
+28,926
+12% +$4.77M 2.16% 15
2023
Q2
$38.6M Sell
233,036
-1,337
-0.6% -$216K 2.07% 16
2023
Q1
$36.3M Sell
234,373
-17,944
-7% -$2.9M 2% 18
2022
Q4
$44.6M Sell
252,317
-4,630
-2% -$799K 2.37% 11
2022
Q3
$42M Sell
256,947
-5,590
-2% -$946K 2.37% 7
2022
Q2
$46.6M Buy
262,537
+3,292
+1% +$587K 2.47% 7
2022
Q1
$45.9M Sell
259,245
-3,525
-1% -$600K 2.11% 14
2021
Q4
$45M Sell
262,770
-4,437
-2% -$726K 2.01% 19
2021
Q3
$43.2M Buy
267,207
+17,090
+7% +$2.92M 1.98% 17
2021
Q2
$41.2M Buy
250,117
+23,073
+10% +$3.82M 1.96% 18
2021
Q1
$37.3M Sell
227,044
-2,426
-1% -$393K 1.95% 16
2020
Q4
$36.1M Sell
229,470
-12,892
-5% -$1.9M 2.11% 13
2020
Q3
$36.1M Sell
242,362
-14,224
-6% -$2.1M 2.37% 7
2020
Q2
$36.1M Sell
256,586
-20,075
-7% -$2.93M 2.45% 10
2020
Q1
$36.3M Sell
276,661
-51,531
-16% -$7.31M 2.67% 8
2019
Q4
$47.9M Buy
328,192
+19,535
+6% +$2.65M 2.38% 12
2019
Q3
$39.9M Sell
308,657
-9,381
-3% -$1.24M 2.01% 17
2019
Q2
$44.3M Sell
318,038
-24,842
-7% -$3.44M 2.18% 15
2019
Q1
$47.9M Buy
342,880
+27,130
+9% +$3.63M 2.15% 14
2018
Q4
$40.7M Buy
315,750
+22,308
+8% +$3.11M 1.84% 16
2018
Q3
$40.5M Buy
293,442
+9,295
+3% +$1.24M 1.49% 25
2018
Q2
$36.4M Hold
284,147
1.33% 31
2018
Q1
$36.4M Sell
284,147
-2,221
-0.8% -$300K 1.33% 31
2017
Q4
$40M Buy
286,368
+2,069
+0.7% +$288K 1.44% 29
2017
Q3
$37M Sell
284,299
-24,404
-8% -$3.24M 1.36% 33
2017
Q2
$40.8M Buy
308,703
+5,551
+2% +$708K 1.48% 27
2017
Q1
$37.8M Buy
303,152
+9,711
+3% +$1.16M 1.34% 32
2016
Q4
$33.8M Sell
293,441
-9,879
-3% -$1.14M 1.2% 35
2016
Q3
$35.8M Sell
303,320
-38,973
-11% -$4.73M 1.33% 32
2016
Q2
$41.5M Sell
342,293
-69,761
-17% -$7.93M 1.57% 25
2016
Q1
$44.6M Sell
412,054
-80,787
-16% -$8.36M 1.52% 31
2015
Q4
$50.6M Sell
492,841
-19,045
-4% -$1.92M 1.58% 26
2015
Q3
$47.8M Sell
511,886
-11,269
-2% -$1.09M 1.45% 30
2015
Q2
$51M Buy
523,155
+46,211
+10% +$4.63M 1.3% 40
2015
Q1
$48M Sell
476,944
-81,431
-15% -$8.28M 1.21% 40
2014
Q4
$58.4M Sell
558,375
-18,162
-3% -$1.91M 1.23% 40
2014
Q3
$61.5M Sell
576,537
-4,781
-0.8% -$496K 1.23% 37
2014
Q2
$60.8M Buy
581,318
+121,927
+27% +$12.3M 1.21% 41
2014
Q1
$45.1M Sell
459,391
-36,927
-7% -$3.42M 1.06% 47
2013
Q4
$45.5M Sell
496,318
-92,354
-16% -$8.51M 1.08% 45
2013
Q3
$51M Sell
588,672
-259,377
-31% -$23.3M 1.39% 32
2013
Q2
$72.8M Buy
+848,049
New +$72M 1.98% 14

Other funds holding JNJ

Seizert Capital Partners's JNJ Position: Q1 2026 in Review

Seizert Capital Partners reduced its Johnson & Johnson (JNJ) stake by 25% in Q1 2026, selling an estimated $13.5M and leaving 171,341 shares worth $41.9M. The position accounts for 1.93% of the portfolio, ranked #23.

Seizert Capital Partners first reported a position in JNJ in Q2 2013 and has held it in 52 quarters since. The position peaked at $72.8M in Q2 2013. 4,618 funds tracked by Wall St. Rank hold JNJ as of Q1 2026.

  • Seizert Capital Partners held 171,341 shares of Johnson & Johnson worth $41.9M as of Q1 2026.
  • Seizert Capital Partners sold 58,131 Johnson & Johnson shares in Q1 2026, an estimated $13.5M.
  • Johnson & Johnson made up 1.93% of Seizert Capital Partners's portfolio in Q1 2026, its #23 holding.
  • Seizert Capital Partners first reported a position in Johnson & Johnson in Q2 2013 and has held it in 52 quarters since.
  • Seizert Capital Partners's Johnson & Johnson position peaked at $72.8M in Q2 2013.
  • 4,618 funds tracked by Wall St. Rank held Johnson & Johnson as of Q1 2026.

Based on Seizert Capital Partners's 13F filing for Q1 2026, filed 7 May 2026.